Triasima Portfolio Management inc. Makes New $4.87 Million Investment in Axon Enterprise, Inc. (NASDAQ:AXON)

Triasima Portfolio Management inc. acquired a new position in Axon Enterprise, Inc. (NASDAQ:AXON) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 8,201 shares of the biotechnology company’s stock, valued at approximately $4,874,000.

Other hedge funds have also bought and sold shares of the company. Golden State Wealth Management LLC purchased a new position in shares of Axon Enterprise during the 4th quarter valued at approximately $691,000. Tobam lifted its position in shares of Axon Enterprise by 41.8% during the 4th quarter. Tobam now owns 1,341 shares of the biotechnology company’s stock valued at $797,000 after buying an additional 395 shares in the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd lifted its position in shares of Axon Enterprise by 10.9% during the 4th quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 8,200 shares of the biotechnology company’s stock valued at $4,873,000 after buying an additional 809 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. lifted its position in shares of Axon Enterprise by 13.5% during the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 180,817 shares of the biotechnology company’s stock valued at $107,463,000 after buying an additional 21,495 shares in the last quarter. Finally, Bleakley Financial Group LLC raised its stake in Axon Enterprise by 1.3% in the 4th quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company’s stock valued at $908,000 after purchasing an additional 20 shares during the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Axon Enterprise Stock Down 0.5 %

Shares of NASDAQ:AXON opened at $677.40 on Friday. The business has a 50-day moving average price of $622.79 and a 200 day moving average price of $491.30. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $51.65 billion, a price-to-earnings ratio of 175.04, a PEG ratio of 6.54 and a beta of 1.05. Axon Enterprise, Inc. has a 12-month low of $255.68 and a 12-month high of $698.67.

Analyst Upgrades and Downgrades

Several research analysts recently commented on AXON shares. Needham & Company LLC increased their price objective on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research note on Friday, November 8th. JMP Securities increased their price objective on Axon Enterprise from $610.00 to $725.00 and gave the company a “market outperform” rating in a research note on Tuesday. The Goldman Sachs Group increased their price objective on Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research note on Monday, January 27th. Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and increased their price objective for the company from $500.00 to $700.00 in a research note on Tuesday, December 3rd. Finally, Robert W. Baird increased their price objective on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. One research analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $542.15.

Insider Activity at Axon Enterprise

In related news, insider Jeffrey C. Kunins sold 21,834 shares of the firm’s stock in a transaction dated Tuesday, November 12th. The stock was sold at an average price of $593.88, for a total transaction of $12,966,775.92. Following the completion of the transaction, the insider now directly owns 154,394 shares in the company, valued at $91,691,508.72. This trade represents a 12.39 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Julie A. Cullivan sold 1,261 shares of the firm’s stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $682.06, for a total value of $860,077.66. Following the transaction, the director now owns 2,392 shares of the company’s stock, valued at $1,631,487.52. This trade represents a 34.52 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 50,545 shares of company stock worth $30,721,337 in the last three months. 5.70% of the stock is owned by company insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.